Home›Search›Frontiers in Anti-infective Drug Discovery
Frontiers in Anti-infective Drug Discovery
Bentham Science Publishers · United Arab Emirates · Est. 2018
ISSN2451-9162
SJR Q4✓ Scopus / SJR
5
/ 100
High Risk
Score Breakdown
✓ Scopus Q4+5
Total5
Journal Impact Factor
Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.
SJR Score
0.133
H-Index
6
Total Works
40
Total Citations
80
2yr Mean Citedness
0.25
Free JIF alternative
Aims & Scope✦ Inferred from recent articles
This journal focuses on the discovery and development of anti-infective agents. It covers research into novel therapeutics for bacterial, viral, and parasitic infections, including strategies to overcome drug resistance. The scope also includes the application of omics technologies, natural products, and alternative approaches like phage therapy in anti-infective drug discovery.
AI-summarised from recent articles · verify on the publisher page
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2018
2019
2020
2021
2024
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Drug DiscoveryQ4
Infectious DiseasesQ4
Molecular MedicineQ4
Subject Classification
Scopus Categories
Drug DiscoveryInfectious DiseasesMolecular Medicine
Research Topics (OpenAlex)
Computational Drug Discovery MethodsBiosimilars and Bioanalytical MethodsLegal Cases and CommentaryDiverse Scientific and Economic StudiesHuman auditory perception and evaluationBacteriophages and microbial interactionsAntibiotic Resistance in BacteriaMosquito-borne diseases and controlMicrobial Natural Products and BiosynthesisSynthesis and biological activity